DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lodoxamide

Lodoxamide

  • Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning

    Prediction of Premature Termination Codon Suppressing Compounds for Treatment of Duchenne Muscular Dystrophy Using Machine Learning

  • Allergies Your Amerigroup Community Care Patients May Experience a Pharmacy Claim Rejection When Prescribed Nonpreferred Products

    Allergies Your Amerigroup Community Care Patients May Experience a Pharmacy Claim Rejection When Prescribed Nonpreferred Products

  • Therapeutic Class Overview Intranasal Histamine H1-Receptor Antagonists (Antihistamines)

    Therapeutic Class Overview Intranasal Histamine H1-Receptor Antagonists (Antihistamines)

  • The Basics of Pharmacology

    The Basics of Pharmacology

  • Protective Effect of Lodoxamide on Hepatic Steatosis Through GPR35 T ⁎ So-Yeon Nam, Soo-Jin Park, Dong-Soon Im

    Protective Effect of Lodoxamide on Hepatic Steatosis Through GPR35 T ⁎ So-Yeon Nam, Soo-Jin Park, Dong-Soon Im

  • National PBM Drug Monograph Epinastine (Elestat™) May 2004 VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel

    National PBM Drug Monograph Epinastine (Elestat™) May 2004 VHA Pharmacy Benefits Management Strategic Healthcare Group and the Medical Advisory Panel

  • Alphabetical Listing of ATC Drugs & Codes

    Alphabetical Listing of ATC Drugs & Codes

  • Supratarsal Injection of Triamcinolone Acetonide in the Treatment of Refractory Vernal Keratoconjunctivitis

    Supratarsal Injection of Triamcinolone Acetonide in the Treatment of Refractory Vernal Keratoconjunctivitis

  • Prior Authorization PDL Implementation Schedule

    Prior Authorization PDL Implementation Schedule

  • Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35

    Lodoxamide Attenuates Hepatic Fibrosis in Mice: Involvement of GPR35

  • BCBSM Clinical Drug List (Formulary)

    BCBSM Clinical Drug List (Formulary)

  • FDA Listing of Established Pharmacologic Class Text Phrases January 2021

    FDA Listing of Established Pharmacologic Class Text Phrases January 2021

  • Emerging Therapeutics for Ocular Surface Disease

    Emerging Therapeutics for Ocular Surface Disease

  • Allergic Conjunctivitis

    Allergic Conjunctivitis

  • Are We Aware of the Risk of Eye Irritation Caused by Some Eyedrops, Paradoxically, in the Treatment of Allergic Conjunctivitis ?

    Are We Aware of the Risk of Eye Irritation Caused by Some Eyedrops, Paradoxically, in the Treatment of Allergic Conjunctivitis ?

  • Comparative Efficacy of Caffeic Acid Phenethyl Ester (CAPE), Olopatadine Hydrochloride, and Dexamethasone Sodium Phosphate in Experimental Allergic Conjunctivitis*

    Comparative Efficacy of Caffeic Acid Phenethyl Ester (CAPE), Olopatadine Hydrochloride, and Dexamethasone Sodium Phosphate in Experimental Allergic Conjunctivitis*

  • Rx Hot Tip Allergies

    Rx Hot Tip Allergies

  • Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline

    Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline

Top View
  • Medicines (Prescription Only) (Jersey) Order 1997
  • Therapeutic Opportunities and Challenges in Targeting the Orphan G Protein-Coupled Receptor GPR35 Tezz Quon, Li-Chiung Lin, Amlan Ganguly, Andrew B
  • Brand Generic Guide
  • Medications to Avoid Prior to Allergy Skin Testing
  • Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
  • Atc Index 2010
  • Antihistamines for Hay Fever and Allergic Rhinitis
  • Poisons List (Jersey) Order 1986
  • For Treating Severe Vernal Keratoconjunctivitis (VKC) Refractory to All Conventional Therapy
  • Immunopharmacology in Vernal Keratoconjunctivitis: Current and Future Perspectives
  • Allergic Rhinitis
  • Conjunctivitis - Allergic, Seasonal & Perennial (1 of 9)
  • California 3 Tier Drug List
  • Section a Changed Classes/Guidelines
  • Commonly Prescribed Systemic Pediatric Medications Pediatric Medications Angela Howell, OD, FAAO, FCOVD Systemic Medications for Non‐Ocular Concerns
  • List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
  • Wo 2007/044693 A2
  • (12) Patent Application Publication (10) Pub. No.: US 2013/0030009 A1 Harish Et Al


© 2024 Docslib.org    Feedback